Frontlight ResearchEarly access
Trial site
Landesklinikum Wr. Neustadt
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company1 trial
- GBG Forschungs GmbH1 trial
Running trials
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026